14 Pharma stocks which have given more than 100 per cent returns

From an investors' point of view, it is quite important to understand the return on a particular stock. The Pharma industry was in the mid of challenges in the last 1 year, and failed to recover fully. However, there are certain stocks which have given more than 100 per cent returns. 

The stocks which have given more than 100 per cent returns are as follows, Medicamen Biotech Ltd., Themis Medicare Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Gennex Laboratories Ltd., Denis Chem Lab Ltd., Auro Laboratories Ltd., Gufic Biosciences Ltd., Mangalam Drugs & Organics Ltd., Source Natural Foods and Herbal Supplements Ltd., Lactose (India) Ltd., Neuland Laboratories Ltd., Alpa Laboratories Ltd., Morepen Laboratories Ltd., and Phaarmasia Ltd.

The major among these is Medicamen which has given a return of more than 500 per cent. The stock 1 year ago was trading at Rs 16.20, but as on July 5, 2016 the shares are trading at Rs 105.90, which is followed by Themis Medicare and Biofil Chemicals & Pharmaceuticals which have given a return of more than 200 per cent. Some other Pharma stocks like Gennex Laboratories, Denis Chem Lab have given a return of 213 and 208 per cent, respectively.

These stocks have performed better than the industry index. The major large cap stocks which have managed to give a better return are Piramal Enterprises, and Biocon which have given a return of more than 50 per cent as compared to July 3, 2015. The only other names which have given a positive return are Aurobindo Pharma, Torrent Pharma, GlaxoSmithKline Pharmaceuticals. Aurobindo Pharma has given a return of 8 per cent whereas Torrent Pharma, and GlaxoSmithKline has given a return of 5.55 and 3.72 per cent, respectively.

The year for the sector was quite challenging. The recent BREXIT implication will have a wider impact on the Indian large cap pharma companies which have a market in the UK.